对比增强能谱乳腺摄影评估乳腺病灶大小:辅助手术决策的有效工具
本研究以术后组织学大小为金标准,比较对比增强能谱乳腺摄影(CESM)、乳腺X线摄影(MG)、超声(US)与乳腺MRI对需手术乳腺病灶大小的评估准确性。共纳入189例患者的233个非良性病灶,结果显示CESM与MRI测值与手术病理大小无统计学差异,而MG与US存在显著差异,提示CESM在病灶大小评估上优于US和MG、与MRI相当。
要点
- CESM测量乳腺病灶最大径与手术病理大小无显著差异,可作为术前大小评估的可靠方法。
- CESM对病灶大小的评估优于MG和US,与MRI表现相当。
- 对需手术的非良性乳腺病灶,CESM有助于制定合适的手术方案。
核心结论
- CESM是评估乳腺病灶大小的可靠方法,其表现似乎优于US和MG,与MRI相当。
研究设计与样本
- 单中心研究,纳入189例患者的233个非良性病灶,所有患者均接受CESM及至少一种其他常规检查(US、MG或MRI)后行手术。
- 以术后组织学标本的病灶大小为金标准,由一名具有10年以上经验的放射科医师测量影像上病灶最大径并与病理大小比较。
- 233个病灶中196个行US评估、206个行MG评估、160个行MRI评估。
诊断标准与关键数值
- CESM与MRI测值同手术病理测值比较均无统计学显著差异(p值分别为0.63和0.51)。
- MG与US测值同手术病理测值比较存在显著差异(p < 0.001)。
临床应用与阅片要点
- 术前可用CESM测量非良性乳腺病灶最大径,为手术范围制定提供参考。
- 当病灶需手术且已行CESM时,其大小评估可信度高于MG和US,可与MRI互为参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the accuracy of Contrast-Enhanced Spectral Mammography (CESM), MG, US, and breast MRI in estimating the size of breast lesions requiring surgery. The postoperative histology size of the lesion was used as the gold standard.
MATERIAL AND METHODS: Two hundred thirty-three non-benign lesions in 189 patients were included in the analyses. All the selected patients underwent CESM and at least one other conventional diagnostic exam (US, MG, or MRI). Subsequently, all the patients underwent surgery preceded by cytological/histological examination. The largest diameter of the lesion at imaging was measured by a radiologist with more than 10 years' experience and then compared with the size of the lesion in the histological sample at the surgery (gold standard).
RESULTS: Among the 233 breast lesions, 196 were evaluated with US, 206 with MG and 160 with MRI. We found no statistically significant differences between size measurements using CESM and MRI compared with the measurements at the surgery (p value 0.63 and 0.51), whereas a significant difference was found for MG and US (p < 0.001).
CONCLUSION: CESM is a reliable method for estimating the size of breast lesions: its performance seems superior to US and MG and comparable to MRI.
引用
- Nicosia, Bozzini, Palma, et al. Contrast-Enhanced Spectral Mammography and tumor size assessment: a valuable tool for appropriate surgical management of breast lesions. Radiol Med. 2022. PMID: 36149581. doi:10.1007/s11547-022-01561-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。